PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: bachelor of science

Injection site reactions - NCIRS

any vaccine but are more common after booster doses of diphtheria, tetanus and pertussis (DTPa/dTpa). The inflammatory changes develop over a few hours following vaccination, peak at 24 to 48 hours and resolve completely within a week. Decreased range of limb movement is uncommon, and the individual is systemically well. ...

Fullscreen Download
Loading..

Tags:

  Tenuta, Pertussis, Tdap, Diphtheria, Tetanus and pertussis

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Documents from same domain

Pertussis vaccines for Australians - NCIRS fact sheet

ncirs.org.au

and 2012. In 2011, 38,732 notified cases were reported nationally . The highest rates of disease were in infants <6 months of age and children 5–9 years of age. Who should be vaccinated • In Australia, pertussis vaccine is available on the National Immunisation Program (NIP) for children at 2, 4, 6, 18 months and 4 years of age.

  Sheet, Rates, Vaccine

[Type text] Meningococcal vaccines - NCIRS

ncirs.org.au

Meningococcal disease is a rare but serious infection caused by the bacterium . Neisseria meningitidis (N. meningitidis). There are 13 serogroups. ... polysaccharides of the organism’s outer membrane capsule. Globally, most cases of meningococcal disease are caused by serogroups A, B, C, W and Y.

  Types, Texts, Vaccine, Meningococcal, Meningococcal vaccines, Type text

Meningococcal vaccines for Australians - NCIRS

ncirs.org.au

Meningococcal vaccines for Australians | 1 July 2020 Fact sheet 3 . The disease . Meningococcal disease is a relatively rare but serious infection caused by the bacterium . Neisseria meningitidis, commonly known as the meningococcus. There are 13 serogroups, distinguished by differences in the surface polysaccharides of the organism’s outer ...

  Meningococcal

Immunisation recommendations for children in Australia

ncirs.org.au

For further details, refer to The Australian Immunisation Handbook. l MenACWY vaccine is recommended for all people ≥6 weeks of age who wish to reduce the likelihood of becoming ill with meningococcal disease, and is strongly recommended for infants and children aged <2 years and adolescents aged 15–19 years.

  Australian, Children

Related documents

NSW School Vaccination Program Year 7

www.health.nsw.gov.au

A combination diphtheria-tetanus-whooping cough vaccine (dTpa) will be offered as a single dose to provide protection against diphtheria, tetanus and whooping cough. This booster dose is essential for maintaining immunity into adulthood after the previous diphtheria-tetanus-whooping cough vaccines given in childhood.

  Tenuta, Tdap, Diphtheria

Related search queries

Diphtheria, Tetanus, DTpa